Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CATM
2026
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $2.27M | ﹤0.01% |
67,400
-37,944
| -36% | -$1.32M |
|
|
FNFV
2027
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $2.26M | ﹤0.01% |
201,000
-39,555
| -16% | -$439K |
|
2028
Embotelladora Andina Series A
AKO.A
$3.58B
| $2.26M | ﹤0.01% |
138,600
+600
| +0.4% | +$10.1K |
|
2029
First Bancorp
FNLC
$394M
| $2.26M | ﹤0.01% |
110,200
+15,706
| +17% | +$327K |
|
|
SGYP
2030
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $2.25M | ﹤0.01% |
+397,600
| New | +$2.42M |
|
2031
QCR Holdings
QCRH
$1.69B
| $2.25M | ﹤0.01% |
92,500
-21,012
| -19% | -$489K |
|
2032
Bank of America
BAC
$433B
| $2.25M | ﹤0.01% |
+133,430
| New | +$2.26M |
|
2033
Las Vegas Sands
LVS
$32.3B
| $2.25M | ﹤0.01% |
+51,200
| New | +$2.33M |
|
|
EXK
2034
Endeavour Silver
EXK
$2.3B
| $2.24M | ﹤0.01% |
1,578,900
+509,900
| +48% | +$791K |
|
|
KAMN
2035
DELISTED
Kaman Corp
KAMN
| $2.24M | ﹤0.01% |
54,900
-50,022
| -48% | -$1.96M |
|
|
TCP
2036
DELISTED
TC Pipelines LP
TCP
| $2.23M | ﹤0.01% |
44,900
-13,032
| -22% | -$645K |
|
2037
Standard BioTools
LAB
$351M
| $2.22M | ﹤0.01% |
205,000
+43,488
| +27% | +$427K |
|
|
GTT
2038
DELISTED
GTT Communications, Inc.
GTT
| $2.21M | ﹤0.01% |
129,700
+78,400
| +153% | +$1.56M |
|
2039
Orrstown Financial Services
ORRF
$841M
| $2.2M | ﹤0.01% |
123,500
+9,300
| +8% | +$164K |
|
2040
Travelzoo
TZOO
$73.3M
| $2.2M | ﹤0.01% |
263,200
+42,200
| +19% | +$371K |
|
2041
American Financial Group
AFG
$11.8B
| $2.2M | ﹤0.01% |
30,500
+9,200
| +43% | +$663K |
|
|
PCOM
2042
DELISTED
Points.com Inc. Common Shares
PCOM
| $2.19M | ﹤0.01% |
228,900
+22,400
| +11% | +$225K |
|
|
N
2043
DELISTED
Netsuite Inc
N
| $2.19M | ﹤0.01% |
+25,900
| New | +$2.22M |
|
|
CSCI
2044
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $2.19M | ﹤0.01% |
4,878
+3,750
| +332% | +$2.35M |
|
2045
Graham Corp
GHM
$1.1B
| $2.18M | ﹤0.01% |
129,800
+21,400
| +20% | +$375K |
|
2046
CenterPoint Energy
CNP
$27.8B
| $2.18M | ﹤0.01% |
118,800
-1,226,042
| -91% | -$21.8M |
|
|
SHOS
2047
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
| $2.18M | ﹤0.01% |
272,500
+133,002
| +95% | +$1.09M |
|
|
ICAD
2048
DELISTED
iCAD Inc
ICAD
| $2.18M | ﹤0.01% |
421,099
+67,239
| +19% | +$267K |
|
2049
Icahn Enterprises
IEP
$5.18B
| $2.18M | ﹤0.01% |
+35,497
| New | +$2.57M |
|
2050
Orion Group Holdings
ORN
$387M
| $2.17M | ﹤0.01% |
520,900
+147,700
| +40% | +$641K |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.